Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017096347) USES OF EXPANDED POPULATIONS OF HEMATOPOIETIC STEM/PROGENITOR CELLS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/096347 International Application No.: PCT/US2016/064908
Publication Date: 08.06.2017 International Filing Date: 05.12.2016
IPC:
C12N 5/02 (2006.01) ,A61K 35/28 (2015.01) ,A61K 35/51 (2015.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
02
Propagation of single cells or cells in suspension; Maintenance thereof; Culture media therefor
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
12
Materials from mammals or birds
28
Marrow; Spleen
[IPC code unknown for A61K 35/51]
Applicants:
FRED HUTCHINSON CANCER RESEARCH CENTER [US/US]; 1100 Fairview Avenue North Seattle, Washington 98109, US
Inventors:
DELANEY, Colleen; US
Agent:
WINGER, C. Rachal; US
Priority Data:
62/263,47004.12.2015US
62/263,57304.12.2015US
Title (EN) USES OF EXPANDED POPULATIONS OF HEMATOPOIETIC STEM/PROGENITOR CELLS
(FR) UTILISATIONS DE POPULATIONS ÉTENDUES DE CELLULES SOUCHES/PROGÉNITRICES HÉMATOPOÏÉTIQUES
Abstract:
(EN) Uses of expanded cord blood hematopoietic stem/progenitor cells (HSPC) are described. Examples include to reduce transplant rejection, to induce immune tolerance, to reduce total parenteral nutrition (TPN) feeding, opioid use, mucositis, and hospitalization following a medical procedure and to reduce graft versus host disease (GVHD) following an allogeneic transplant.
(FR) Utilisations de populations étendues de cellules souches/cellules progénitrices hématopoïétiques (HSPC) de sang ombilical. Les exemples comprennent la réduction du rejet de greffe, l'induction de tolérance immunitaire, la réduction de l'alimentation parentérale totale (APT), l'utilisation d'opioïdes, la mucosite, et l'hospitalisation après une procédure médicale et la réduction de la maladie du greffon contre l'hôte (GVH) après une allogreffe.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU2016364934CA3005767KR1020180085018CN108473949EP3384006IN201817024778
US20180353541BR112018011327